Drupal.behaviors.print = function(context) {window.print();window.close();}>
Qiagen, Eli Lilly Ink Companion Dx Deal for JAK2 Inhibitor
September 06, 2011
Qiagen, Eli Lilly Ink Companion Dx Deal for JAK2 Inhibitor
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Qiagen, Eli Lilly Enter CDx Deal
February 14, 2013 / GenomeWeb Daily News
Qiagen, Bayer Partner on Cancer Companion Dx
October 25, 2012 / GenomeWeb Daily News
FDA Clears Qiagen KRAS Test as CDx for Erbitux
July 9, 2012 / GenomeWeb Daily News
PrimeraDx Developing Assays for Eli Lilly's Drug Development Programs
June 26, 2012 / GenomeWeb Daily News
Cepheid, Novartis Partner to Bring Leukemia Test to US
October 8, 2010 / GenomeWeb Daily News